The "Little Giant" enterprises with specialization and innovation, is an honorary award established by the state to encourage small and medium-sized enterprises to achieve development in four aspects: specialized operation, refined output, distinctive craftsmanship, and novel products. The aim is to cultivate a group of "pioneering" enterprises that focus on niche markets, possess strong innovation capabilities, high market share, mastery of key core technologies, and excellent quality and efficiency. These enterprises are dedicated to targeting market gaps and industry pain points for in-depth research and cultivation.Need to meet the six aspects of indicators: specialization, refinement, uniqueness, innovation, chain, and product simultaneously.Demonstrate irreplaceable competitive advantages.

This evaluation is a high recognition of METiS TechBio's technological innovation, R&D investment, and the transformation of scientific and technological achievements.As a global leading "AI + nanomaterials" drug delivery technology platform,METiS TechBio, in the absence of open-source datasets and delivery-related algorithms, started from scratch to innovatively develop groundbreaking artificial intelligence and computational simulation algorithms for ionizable lipid generation and design, as well as LNP nanomaterial design and simulation. Combined with world-leading high-throughput experimental techniques and animal validation platforms, METiS TechBio has established its own data and algorithmic barriers., achieving a number of industry-leading technological innovations.

Learn More About METiS TechBio